The near-term outlook for pharma earnings; an unlikely crusader winning the fight on hospital prices

Taking stock of the drug industry, from the lab to the medicine chest ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by   STAT+: The near-term outlook for pharma industry earnings just got a little worse By Ed Silverman APStock The primary driver for the change in outlook by Moody’s Investor Service is concern about looming patent expirations. Read More The unlikely crusader who's winning the fight to lower hospital prices By Rachel Cohrs Adobe Al Hubbard has been driving a remarkably successful campaign to lower extraordinarily high hospital prices in Indiana. Read More Democrats tweak their drug pricing plan in last-ditch effort to pass reforms By Rachel Cohrs J. Scott Applewhite/AP Photo Senate Democrats are vetting a new, tweaked version of a drug pricing package as they hurtle toward a September deadline to pass reforms. Read More Sponsor content by STAT Events Democrats’ Last Chance for Drug Pricing Reform? The drug pricing debate remains a central conversation in Congress. On July 20, STAT sits down with key decision-makers about the latest developments from Capitol Hill and the White House. Join them. STAT+: New analysis of Amarin's Vascepa resurrects big questions about effectiveness By Matthew Herper Adobe Some experts say the questions require a new clinical trial to be run, and some even say the FDA should reconsider the product’s approval. Read More Listen: Medical privacy post-Roe, fixing clinical trials, & the next Covid vaccines By Damian Garde and Meg Tirrell and Adam Feuerstein This week, our colleague Eric Boodman joins us to discuss whether HIPAA can shield reproductive health data from state law enforcement. Read More Thursday, June 30, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser